Contact Us   |   Sign In   |   Join CAHR
Market Access 201
Share |

MARKET ACCESS 201

Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

TUESDAY, JUNE 13, 2017
Old Mill - Meeting Rooms Guildhall A & B
21 Old Mill Road, Toronto, ON, M8X 1G5

Join us for Market Access 201 as we explore the evolving public and private reimbursement landscape in Canada, and discuss whether the market access pathways for these payers are parallel or intersecting.

Anyone who wants to learn more about market access should consider joining us, and if you are seeking your
Market Access Certification through our CMAP program this is a must-attend event!

COST: Includes conference materials, breakfast, lunch and two coffee breaks. 
CAHR
Member:  $850.00    Non-Member: $995.00      Student: $75.00 (13% HST is applicable)


AGENDA

  7:00AM

REGISTRATION & BREAKFAST

 

EMCEE FOR THE DAY:
Jeffrey Hoch, PhD, Professor, Department of Public Health Sciences, Associate Director, Center for Healthcare Policy and Research UC Davis

  9:00AM

WELCOME & OPENING REMARKS

  9:15AM













PANEL ONE: Biosimilars
Given the upcoming launch of multiple biosimilars for the same agent and the ongoing pCPA Biologic/Biosimilar Consultation, this discussion panel will focus on the recent developments surrounding biosimilars from the pCPA and public payer perspective and contrast that with developments in the private payer market.

MODERATOR:
Dr. Judith Glennie, President, J.L. Glennie Consultants

PANELISTS:
Imran Ali, Senior Manager, pan-Canadian Pharmaceutical Alliance (pCPA)
Judy McPhee, Former Executive Director of Pharmaceutical Services and Extended Health Benefits, Nova Scotia Department of Health and Wellness
Ned Pojskic, Pharmacy Strategy Leader, Green Shield Canada

10:00AM

NETWORKING BREAK

10:30AM












PANEL TWO: Quebec
A number of important changes are emerging in Quebec over the coming months (e.g. INESSS will be changing its framework for evaluation and issuing guidelines on biosimilars).  In addition, the implementation of Bill 92 will restrict the use of co-pay cards which may have significant impact on patient assistance programs in that province.  This panel will discuss the upcoming changes in Quebec and their implications on the industry and the healthcare system.

MODERATOR: Sebastien Dao, Managing Principal, Synergyx Consulting Inc.

PANELISTS:

Adrienne Blanchard, Founder, Blanchard Law

Lyne Duhaime, President, ACCAP-Quebec

11:15AM
















PANEL THREE: Health Technology Assessment
This panel will explore current developments and the evolving role of health technology assessment for both public and private drug plans. We will discuss CADTH’s increasingly important role with the pCPA in terms of therapeutic reviews, requests for advice and price reduction analyses, as well as the potential for CADTH to develop closer alignment with other key stakeholders like Health Canada and INESSS. With respect to private payers, we will investigate how private payers are approaching and utilizing HTA in an environment of increased scrutiny of specialty drug products.

MODERATOR:
Chander M. Sehgal, MBA, MD, Executive Director, Access & Reimbursement Policy, Innovative Medicines Canada

PANELISTS:
Trevor Richter, Director, Common Drug Review and Optimal Use, CADTH
Helen Stevenson, BCom, MSM, ICD.D, Founder and CEO, Reformulary Group Inc.



12:00PM

LUNCH & NETWORKING

  1:00PM













PANEL FOUR: pan-Canadian Pharmaceutical Alliance (pCPA)
This panel will focus on recent events surrounding the pCPA and the results of an analysis on implicit PLA prioritization.  The presentations will be followed by a discussion that includes representatives from the pCPA Office and a public payer to solicit their views on latest activities at the pCPA and how they see the future evolving.

MODERATOR:
Sherry O’Quinn, Managing Principal, MORSE Consulting Inc.

PANELISTS:

Imran Ali, Senior Manager, pan-Canadian Pharmaceutical Alliance (pCPAO)   

Judy McPhee, Former Executive Director of Pharmaceutical Services and Extended Health Benefits, Nova Scotia Department of Health and Wellness

Angela Rocchi‎, Principal, ‎Athena Research Inc



   2:00PM

NETWORKING BREAK

   2:30PM














PANEL FIVE: Patented Medicine Prices Review Board (PMPRB)
This panel will focus on the PMPRB’s Guidelines Modernization initiative and regulatory changes that may impact the PMPRB. There will be a presentation from a PMPRB representative and some perspective from a pricing expert on its implications to manufacturers.  Given the increasing interest of private payers on PMPRB’s activities, a private payer representative will also provide some viewpoints on changes at the PMPRB.

MODERATOR: John-Paul Dowson, Managing Director, Roubaix Strategies

PANELISTS:
Tanya Potashnik, Director, Policy and Economic Analysis Branch, Patented Medicine Prices Review Board (PMPRB)
Joan McCormick, Principal, Price Regulation, Consulting, QuintilesIMS
Anjila Arora, Director, Pharmaceutical Benefits, Sun Life Financial

  3:15PM















FINAL DISCUSSION & PANEL: Public & Private Payer Future Directions

The final panel will address the key changes they see emerging over the next 2 or 3 years, including new federal proposals to address sustainability and improve transparency. Threats and opportunities will be identified, including the implications of closer collaboration between payers. Finally, we'll consider how pharmaceutical companies can best prepare for and influence the pace and direction of change.


MODERATOR:
Chris Bonnett, Principal Consultant, H3 Consulting

PANELISTS:

Ben Faienza, Director of Market Access and Government Relations, UCB Canada Inc.
Chris Goguen, Strategic Pharmaceutical Partnerships Lead at Medavie Blue Cross

Judy McPhee, Former Executive Director of Pharmaceutical Services and Extended Health Benefits, Nova Scotia Department of Health and Wellness



   4:15PM

Q&A / CONCLUSION

   4:30PM
PROGRAM ENDS
 CAHR reserves the right to cancel or change speakers, program content and date without prior notice.
We assume no liability for these changes
.





 Thank you to all our event partners!
     
 
 

 
Membership Software Powered by YourMembership  ::  Legal